Replies to post #676365 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Continued: Got it? Now read this with a more discerning eye.

Status In progress — NICE

05 March 2024 A meeting was held between NICE and the company in early-February regarding next steps for the appraisal of DCVax-L for treating glioblastoma, and more information WILL BE AVAILABLE in due course. NICE will continue liaising with the company and monitoring timelines. — NICE

3.1.5 If possible, NICE informs consultees and commentators about timeline changes during an appraisal and the reasons for these changes. Sometimes, however, if the reasons are COMMERCIALLY SENSITIVE, NICE cannot disclose the details. Nice works with the company to release as much information as possible to consultees and commentators, and on the NICE website. — https://www.nice.org.uk/process/pmg19/chapter/the-appraisal-process